CryoLife : CryoArtery® Aortoiliac Artery

CryoArtery® Aortoiliac Artery

Although the incidence of infection of the abdominal aortic graft is low, conventional treatment is complex and the outcome can be devastating. The use of synthetic graft alternatives are often not an option for placement directly in an infected field. Conventional treatment methods, such as an extra-anatomical bypass procedure, have been clinically demonstrated to be a costly and clinically inefficient option when compared to the outcomes achieved with cryopreserved arterial allografts. CryoArtery^® Aortoiliac allografts provide a safe and effective treatment option for
mycotic aneurysms, synthetic graft infections, and aortoenteric fistulas in an infected field.

Clinical Results
Below are clinical results from Vogt, et al,¹ highlighting clinical outcomes for allografts.
	Extra-anatomic Bypass	Allograft
Follow-up (months)	Median: 34 Range: 10-84	Median: 25 Range: 0-83
Surgery/Infection-Related Mortality	32%	12%
Reoperation	45%	9%
Infection Completely Eliminated	53%	91%
Time in ICU (days)	Median: 11 Range: 2-120	Median: 1 Range: 1-42
Duration of Hospital Stay (days)	Median: 30 Range:15-240	Median: 14 Range7-150

_{¹ Vogt PR, et al., Cryopreserved arterial allografts in the treatment of major vascular infection: A comparison with conventional surgical techniques. J Thorac Cardiovasc Surg 1998;116:965-72}

Applications

The aortoiliac arterial conduit is transected including the renal arteries and iliac artery branches. Excess fat and loose adventitia are removed from the graft. Small artery branches are suture ligated.

Availability: 5.0 mm minimal internal diameter, 5.0 cm minimal length